Digoxin vs Ipilimumab

Digoxin vs Ipilimumab: Overview

This comparison examines the pharmacological differences between Digoxin and Ipilimumab.

Mechanism of Action

Digoxin: Inhibits Na+/K+-ATPase, increasing intracellular calcium.

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Pharmacokinetics

Half-life: Digoxin — 36-48 hours; Ipilimumab — 14.7 days.

Chemical Properties

Molecular Formula: Digoxin — C41H64O14.

Molecular Weight: Digoxin — 780.9430 g/mol.

Type: Digoxin — Small molecule; Ipilimumab — Antibody.